MITCHELL DEAN J
SEC insider (Form 3/4/5 filer). CIK 0001199297. Director at Theravance Biopharma, Inc. (TBPH) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies MITCHELL DEAN J has filed insider reports for
- Theravance Biopharma, Inc. (TBPH): Director
- Praxis Precision Medicines, Inc. (PRAX): Director
MITCHELL DEAN J
CIK: 0001199297
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect91.2K shares- - Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect6K shares- - Jun 12, 2026TBPH
Theravance Biopharma, Inc.
AwardDirect6K shares- - Jun 10, 2026PRAX
Praxis Precision Medicines, Inc.
AwardDirect1.4K shares- - Sep 24, 2025PRAX
Praxis Precision Medicines, Inc.
ExerciseDirect1.9K shares at avg. $14.36$28K - Sep 24, 2025PRAX
Praxis Precision Medicines, Inc.
ExerciseDirect8.6K shares at avg. $44.25$379K - Sep 24, 2025PRAX
Praxis Precision Medicines, Inc.
ExerciseDirect1.8K shares at avg. $44.04$77K - Jun 26, 2025PRAX
Praxis Precision Medicines, Inc.
AwardDirectStock Option (Right to Buy)
10.5K shares- - May 19, 2025TBPH
Theravance Biopharma, Inc.
AwardDirect10.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  TBPH Theravance Biopharma, Inc. | Disposition | 91,204 | - | $0 | Direct |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 6,009 | - | $0 | Direct |
| Jun 12, 2026 | TBPH Theravance Biopharma, Inc. | Award | 6,009 | - | $0 | Direct |
| Jun 10, 2026 |  PRAX Praxis Precision Medicines, Inc. | Award | 1,371 | - | $0 | Direct |
| Sep 24, 2025 | PRAX Praxis Precision Medicines, Inc. | Exercise | 1,932 | $14.36 | $27,744 | Direct |
| Sep 24, 2025 | PRAX Praxis Precision Medicines, Inc. | Exercise | 8,566 | $44.25 | $379,046 | Direct |
| Sep 24, 2025 | PRAX Praxis Precision Medicines, Inc. | Exercise | 1,753 | $44.04 | $77,202 | Direct |
| Jun 26, 2025 | PRAX Praxis Precision Medicines, Inc. | Award Stock Option (Right to Buy) | 10,520 | - | - | Direct |
| May 19, 2025 | TBPH Theravance Biopharma, Inc. | Award | 10,649 | - | - | Direct |
1-9 of 9 transactions